Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $7 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $15.75 per share a year ago.

(Operator Instructions) Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31 ...

Good morning, and thank you all for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended December 31st, 2024 and provided ...

NATICK, Mass., April 03, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that its Special Meeting of Stockholders ...

(Operator Instructions) Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31, ...

In a recent development, Allurion Technologies, Inc., a medical device company specializing in surgical and medical instruments, announced the approval of several key proposals by its stockholders.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, a swallowable and procedure-less ...

In a recent development, Allurion Technologies, Inc., a medical device company specializing in surgical and medical instruments, announced the approval of several key proposals by its stockholders.